NCT00527839 Hospital for Special Surgery Shoulder Arthroplasty Cohort
| NCT ID | NCT00527839 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital for Special Surgery, New York |
| Condition | Shoulder Arthroplasty |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2007-04 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2007-04 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes. HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here. The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.
Eligibility Criteria
Inclusion Criteria: * 18 years or older and undergoing total shoulder arthroplasty at HSS Exclusion Criteria: * No other exclusion criteria. Pregnant women are eligible for the registry as this is a non-interventional study which only involves filling out questionnaires.
Contact & Investigator
Robert Marx, MD
PRINCIPAL INVESTIGATOR
Hospital for Special Surgery, New York
Frequently Asked Questions
Who can join the NCT00527839 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Arthroplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00527839 currently recruiting?
Yes, NCT00527839 is actively recruiting participants. Contact the research team at marxr@hss.edu for enrollment information.
Where is the NCT00527839 trial being conducted?
This trial is being conducted at New York, United States, New York, United States.
Who is sponsoring the NCT00527839 clinical trial?
NCT00527839 is sponsored by Hospital for Special Surgery, New York. The principal investigator is Robert Marx, MD at Hospital for Special Surgery, New York. The trial plans to enroll 250 participants.